Literature DB >> 11807956

A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin.

Maralee McVean1, Wendy C Weinberg, Jill C Pelling.   

Abstract

Apigenin, a nonmutagenic flavonoid, has been shown to inhibit ultraviolet light-induced skin tumorigenesis when topically applied to mouse skin. Our previous studies have shown that apigenin treatment of cultured mouse keratinocytes induces G(2)/M arrest accompanied by an increase in p53 protein stability and expression of p21(waf1). In this study, we determined whether the G(2)/M arrest induced by apigenin was dependent upon the presence of the cyclin dependent kinase inhibitor p21(waf1). We exposed WWT.8 (p21(waf1) wild-type) and WKO.16 (p21(waf1) null) mouse keratinocytes to various doses of apigenin for 24 h and observed G(2)/M arrest in both cell lines, thereby establishing that the apigenin-induced G(2)/M arrest was p21(waf1) independent. A 4-h treatment with apigenin induced increases in p53 protein level by sixfold and tenfold in the WWT.8 p21(waf1) wild-type cells and WKO.16 p21(waf1) null cells, respectively. After 24 h in WWT.8 cells, p21(waf1) protein also was induced in a dose-dependent manner, but it was not expressed in WKO.16 keratinocytes. We then measured the effect of apigenin treatment on the mammalian homologue of the yeast cdc2 gene (p34(cdc2)) cyclin-dependent kinase and cyclin B1 (cycB1), because these proteins complex to regulate G(2)/M progression. Apigenin treatment decreased the protein level of p34(cdc2), and p34(cdc2) kinase activity was inhibited in both p21(waf1)(+/+) and p21(waf1)(-/-) cell lines by approximately 40%. The inhibition of p34(cdc2) kinase activity by apigenin treatment correlated with increasing levels of p34(cdc2) phosphorylation at Tyr15, a site in the p34(cdc2) kinase that undergoes inhibitory phosphorylation by Wee1 kinase. Apigenin treatment also had no effect on the protein level or activity of the competing phosphatase, cdc25c, which dephosphorylates p34(cdc2) kinase at Tyr15. Apigenin had little effect on the accumulation of cycB1 protein. These results supported the conclusion that G(2)/M arrest induced by apigenin was accompanied by inhibition of the p34(cdc2) cyclin-dependent kinase protein level and activity in a p21(waf1)-independent manner. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807956     DOI: 10.1002/mc.10016

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  11 in total

1.  Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes: A new implication of skin cancer prevention.

Authors:  Bryan B Bridgeman; Pu Wang; Boping Ye; Jill C Pelling; Olga V Volpert; Xin Tong
Journal:  Cell Signal       Date:  2016-02-12       Impact factor: 4.315

2.  Cancer chemopreventive properties of orally bioavailable flavonoids--methylated versus unmethylated flavones.

Authors:  Thomas Walle; Nga Ta; Toshihiko Kawamori; Xia Wen; Petra A Tsuji; U Kristina Walle
Journal:  Biochem Pharmacol       Date:  2006-12-28       Impact factor: 5.858

3.  Apigenin, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NF-kappaB activation pathway.

Authors:  Luting Xu; Li Zhang; Anne M Bertucci; Richard M Pope; Syamal K Datta
Journal:  Immunol Lett       Date:  2008-09-21       Impact factor: 3.685

Review 4.  Anticancer potential of the histone deacetylase inhibitor-like effects of flavones, a subclass of polyphenolic compounds: a review.

Authors:  Prabhat Singh; Raghuvir Singh Tomar; Srikanta Kumar Rath
Journal:  Mol Biol Rep       Date:  2015-06-02       Impact factor: 2.316

Review 5.  Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.

Authors:  Xin Tong; Jill C Pelling
Journal:  Anticancer Agents Med Chem       Date:  2013-09       Impact factor: 2.505

6.  Apigenin induces DNA damage through the PKCδ-dependent activation of ATM and H2AX causing down-regulation of genes involved in cell cycle control and DNA repair.

Authors:  Daniel Arango; Arti Parihar; Frederick A Villamena; Liwen Wang; Michael A Freitas; Erich Grotewold; Andrea I Doseff
Journal:  Biochem Pharmacol       Date:  2012-09-14       Impact factor: 5.858

Review 7.  Cancer prevention with promising natural products: mechanisms of action and molecular targets.

Authors:  Poyil Pratheeshkumar; Chakkenchath Sreekala; Zhuo Zhang; Amit Budhraja; Songze Ding; Young-Ok Son; Xin Wang; Andrew Hitron; Kim Hyun-Jung; Lei Wang; Jeong-Chae Lee; Xianglin Shi
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

8.  Apigenin reactivates Nrf2 anti-oxidative stress signaling in mouse skin epidermal JB6 P + cells through epigenetics modifications.

Authors:  Ximena Paredes-Gonzalez; Francisco Fuentes; Zheng-Yuan Su; Ah-Ng Tony Kong
Journal:  AAPS J       Date:  2014-05-16       Impact factor: 4.009

9.  Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest.

Authors:  Michael B Ujiki; Xian-Zhong Ding; M Reza Salabat; David J Bentrem; Laleh Golkar; Ben Milam; Mark S Talamonti; Richard H Bell; Takeshi Iwamura; Thomas E Adrian
Journal:  Mol Cancer       Date:  2006-12-29       Impact factor: 27.401

10.  Apigenin Inhibits Tumor Necrosis Factor-α-Induced Production and Gene Expression of Mucin through Regulating Nuclear Factor-Kappa B Signaling Pathway in Airway Epithelial Cells.

Authors:  Hyo-Seok Seo; Mohamed Asaduzzaman Sikder; Hyun Jae Lee; Jiho Ryu; Choong Jae Lee
Journal:  Biomol Ther (Seoul)       Date:  2014-11-30       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.